Optimal dosage of cyclopentolate 1% for complete cycloplegia: a randomized clinical trial.

  title={Optimal dosage of cyclopentolate 1% for complete cycloplegia: a randomized clinical trial.},
  author={Abbas Bagheri and Soudabeh Givrad and Shahin Yazdani and M Reza Mohebbi},
  journal={European journal of ophthalmology},
  volume={17 3},
PURPOSE To determine the optimal dosage of cyclopentolate for adequate cycloplegia with minimal side effects. METHODS A prospective randomized clinical trial of patients 3.5 to 20 years of age referred to a strabismus clinic during a 1-year period. Eligible patients were randomly divided into three groups. In Group 1, the cycloplegic effect of one drop of cyclopentolate was compared with two drops; in Group 2, the effect of two drops was compared with three drops; and in Group 3, the effect… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
7 Citations
21 References
Similar Papers


Publications referenced by this paper.
Showing 1-10 of 21 references

Mydriatic and cycloplegic agents

  • A Vitale, CS Foster
  • 1997
Highly Influential
4 Excerpts

Clinical Management of Strabismus

  • EE Caloroso, MW Rouse, SA. Cotter
  • Boston: Butterworth-Heinemann,
  • 1993
Highly Influential
4 Excerpts

Ocular Pharmacology

  • WH Havener
  • 5th ed. St. Louis: Mosby,
  • 1978
Highly Influential
4 Excerpts

Optics, refraction and contact lenses in basic and clinical science course

  • TJ Liesgang, TA Deutsch, MG. Grand
  • Found Am Acad Ophthalmol 2004–2005;
  • 2005
2 Excerpts

Therapeutic Drugs. 2nd ed

  • C. Dollery
  • New York: Churchill Livingstone,
  • 1999
1 Excerpt

Refraction in infants and children

  • MX Repka
  • Nelson LB, ed. Harley’s Pediatric Ophthalmology…
  • 1998
3 Excerpts

Similar Papers

Loading similar papers…